These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27603291)

  • 1. Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    Tjiam MC; Sariputra L; Armitage JD; Taylor JP; Kelleher AD; Tan DB; Lee S; Fernandez S; French MA
    AIDS; 2016 Nov; 30(18):2757-2765. PubMed ID: 27603291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.
    Tjiam MC; Taylor JP; Morshidi MA; Sariputra L; Burrows S; Martin JN; Deeks SG; Tan DB; Lee S; Fernandez S; French MA
    J Immunol; 2015 Jun; 194(11):5320-8. PubMed ID: 25911748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia.
    Voltersvik P; Albrektsen G; Ulvestad E; Dyrhol-Riise AM; Sørensen B; Asjö B
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):358-67. PubMed ID: 14615653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.
    Adalid-Peralta L; Grangeot-Keros L; Rudent A; Ngo-Giang-Huong N; Krzysiek R; Goujard C; Deveau C; Le Gall M; Meyer L; Emilie D; Rouzioux C
    HIV Med; 2006 Nov; 7(8):514-9. PubMed ID: 17105510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors.
    Sadanand S; Das J; Chung AW; Schoen MK; Lane S; Suscovich TJ; Streeck H; Smith DM; Little SJ; Lauffenburger DA; Richman DD; Alter G
    AIDS; 2018 Feb; 32(4):443-450. PubMed ID: 29239894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection.
    Viana IFT; Coêlho DF; Palma ML; Nascimento EJM; Gu G; Lima LFO; Foti L; Krieger MA; Pilcher C; Calzavara-Silva CE; Mailliard RB; Rinaldo CR; Dhalia R; Marques ETA
    Epidemiol Infect; 2018 Jul; 146(10):1293-1300. PubMed ID: 29925445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men.
    Pillay T; Sobia P; Olivier AJ; Narain K; Liebenberg LJP; Ngcapu S; Mhlongo M; Passmore JS; Baxter C; Archary D
    Front Immunol; 2018; 9():3141. PubMed ID: 30728825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load.
    Baiyegunhi O; Ndlovu B; Ogunshola F; Ismail N; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.
    Banerjee K; Klasse PJ; Sanders RW; Pereyra F; Michael E; Lu M; Walker BD; Moore JP
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):445-58. PubMed ID: 20377426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
    Techakriengkrai N; Tansiri Y; Hansasuta P
    AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
    Ngo-Giang-Huong N; Candotti D; Goubar A; Autran B; Maynart M; Sicard D; Clauvel JP; Agut H; Costagliola D; Rouzioux C;
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1435-46. PubMed ID: 11679156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of HIV-1-specific antibody responses.
    Curtis KA; Kennedy MS; Owen SM
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1099-105. PubMed ID: 25314631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and salivary IgG subclasses in HIV type 1 infection: evidence of both transudation and local synthesis of IgG in parotid saliva.
    Wu X; Jackson S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1423-31. PubMed ID: 11018862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.